Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
Үндсэн зохиолчид: | Glynne-Jones, R, Sebag-Montefiore, D, Samuel, L, Falk, S, Maughan, T, McDonald, A |
---|---|
Формат: | Conference item |
Хэвлэсэн: |
2005
|
Ижил төстэй зүйлс
-
Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
-н: Glynne-Jones, R, зэрэг
Хэвлэсэн: (2004) -
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
-н: Sebag-Montefiore, D, зэрэг
Хэвлэсэн: (2005) -
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
-н: Glynne-Jones, R, зэрэг
Хэвлэсэн: (2007) -
Capecitabine (X) and oxaliplatin (O) combination chemotherapy in patients (pts) with advanced gall bladder or biliary tract cancer: A phase II study
-н: Evans, T, зэрэг
Хэвлэсэн: (2006) -
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
-н: Anchuan Li, зэрэг
Хэвлэсэн: (2022-07-01)